Search results
Results from the WOW.Com Content Network
The drug policy of the Philippines is guided by the Comprehensive Dangerous Drugs Act of 2002 and is implemented by the Dangerous Drugs Board with its implementing arm, the Philippine Drug Enforcement Agency along with other member agencies. Aside from regulating and prohibiting the usage, sale, production of certain drugs, the 2002 law is ...
An online version is available, with all drug listings available to view for free. Concise drug monographs form the core of MIMS; these include safety information, details of the active ingredient, presentation, price, indication, dosage and manufacturer. In addition, the book includes drug comparison tables, and summaries of clinical guidance.
Use, sale, acquisition, possession, cultivation, manufacture and distribution of prohibited and regulated drugs and other similar substances as provided for under pertinent laws; Prosecution of offenders, and rehabilitation of drug users and dependents, including the formulation of drug-related policies
The Comprehensive Dangerous Drugs Act of 2002, officially designated as Republic Act No. 9165, is a consolidation of Senate Bill No. 1858 and House Bill No. 4433.It was enacted and passed by the Senate of the Philippines and House of Representatives of the Philippines on May 30 and 29, 2002, respectively.
The Philippine Drug Enforcement Agency (PDEA, / p iː ˈ d eɪ ə /; [1] Filipino: Ahensiya ng Pilipinas sa Pagpapatupad ng Batas Laban sa Bawal na Gamot [2]) is the lead anti-drug law enforcement agency, responsible for preventing, investigating and combating any dangerous drugs, controlled precursors and essential chemicals within the Philippines.
The Food and Drug Administration (FDA) of the Philippines, formerly the Bureau of Food and Drugs (BFAD / ˈ b iː f æ d /; 1982–2009), is a health regulatory agency under the Department of Health created on 1963 by Republic Act No. 3720, amended on 1987 by Executive Order 175 otherwise known as the "Food, Drugs and Devices, and Cosmetics Act", and subsequently reorganized by Republic Act No ...
In the US, where a system of quasi-private healthcare is in place, a formulary is a list of prescription drugs available to enrollees, and a tiered formulary provides financial incentives for patients to select lower-cost drugs. For example, under a 3-tier formulary, the first tier typically includes generic drugs with the lowest cost sharing ...
The Philippine House Committee on Dangerous Drugs, or House Dangerous Drugs Committee is a standing committee of the Philippine House of Representatives. Jurisdiction [ edit ]